Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Aug-22 4:55 PM View:  | Seth Sandesh Chief Executive Officer Director | Actinium Pharmaceuticals, I... (ATNM) | 17-Aug-22 | Grant | 300,000 | -- | -- | 5575% 5.38K to 305.38K | |
| 07-Mar-19 4:15 PM View: | Berger Mark Stanley Chief Medical Officer | Actinium Pharmaceuticals, I... (ATNM) | 05-Mar-19 | Exercise (in-the money or at-the-money) | 3,500 | $0.60 | $2,100.00 | 18% 19.0K to 22.5K | |
| 21-Feb-19 4:45 PM View: | Seth Sandesh Chairman & CEO Director | Actinium Pharmaceuticals, I... (ATNM) | 21-Feb-19 | Exercise (in-the money or at-the-money) | 8,125 | $0.60 | $4,875.00 | 5% 153.33K to 161.46K | |
| 10-Dec-18 4:10 PM View: | O'Loughlin Steve Principal Financial Officer | Actinium Pharmaceuticals, I... (ATNM) | 10-Dec-18 | Purchase | 10,000 | $0.44 | $4,350.00 | 39% 25.5K to 35.5K | |
| 10-Dec-18 4:14 PM View: | Seth Sandesh Chairman & CEO Director | Actinium Pharmaceuticals, I... (ATNM) | 10-Dec-18 | Purchase | 10,000 | $0.44 | $4,372.00 | 7% 143.33K to 153.33K | |
| 20-Nov-18 5:08 PM View: | Ludwig Dale L. Chief Scientific Officer | Actinium Pharmaceuticals, I... (ATNM) | 19-Nov-18 | Purchase | 10,000 | $0.45 | $4,499.00 | 100% 0 to 10.0K | |
| 17-Jul-18 5:13 PM View: | Seth Sandesh CEO Director | Actinium Pharmaceuticals, I... (ATNM) | 17-Jul-18 | Purchase | 10,000 | $0.79 | $7,900.00 | 8% 133.33K to 143.33K | |
| 15-Jun-18 6:08 PM View: | O'Loughlin Steve Principal Financial Officer | Actinium Pharmaceuticals, I... (ATNM) | 15-Jun-18 | Purchase | 12,000 | $0.50 | $6,000.00 | 89% 13.5K to 25.5K | |
| 20-Apr-18 4:15 PM View: | Seth Sandesh Chairman & CEO Director | Actinium Pharmaceuticals, I... (ATNM) | 19-Apr-18 | Purchase | 5,000 | $0.38 | $1,900.00 | 4% 128.33K to 133.33K | |
| 08-Mar-18 4:20 PM View: | O'Loughlin Steve Principal Financial Officer | Actinium Pharmaceuticals, I... (ATNM) | 06-Mar-18 | Acquisition (other) | 10,000 | $0.50 | $5,000.00 | 286% 3.5K to 13.5K | |
| 08-Mar-18 4:35 PM View: | Seth Sandesh Chairman & CEO Director | Actinium Pharmaceuticals, I... (ATNM) | 06-Mar-18 | Acquisition (other) | 52,500 | $0.50 | $26,250.00 | 69% 75.83K to 128.33K | |
| 08-Mar-18 4:32 PM View: | Ray Nitya G. Executive VP | Actinium Pharmaceuticals, I... (ATNM) | 06-Mar-18 | Acquisition (other) | 10,000 | $0.50 | $5,000.00 | 100% 10.0K to 20.0K | |
| 08-Mar-18 4:24 PM View: | Steinhart Richard I Director | Actinium Pharmaceuticals, I... (ATNM) | 06-Mar-18 | Acquisition (other) | 7,000 | $0.50 | $3,500.00 | 280% 2.5K to 9.5K | |
| 19-Mar-18 5:04 PM View: | Berger Mark Stanley Chief Medical Officer | Actinium Pharmaceuticals, I... (ATNM) | 06-Mar-18 | Acquisition (other) | 14,000 | $0.50 | $7,000.00 | 280% 5.0K to 19.0K | |
| 01-Mar-18 7:08 AM View: | Shetty Ajit Director | Actinium Pharmaceuticals, I... (ATNM) | 28-Feb-18 | Purchase | 22,730 | $0.43 | $9,773.90 | 100% 0 to 22.73K | |
| 04-Aug-17 4:22 PM View: | Ray Nitya G. Executive Vice President | Actinium Pharmaceuticals, I... (ATNM) | 02-Aug-17 | Purchase | 10,000 | $0.75 | $7,500.00 | 100% 0 to 10.0K | |
| 04-Aug-17 4:35 PM View: | Seth Sandesh Chairman & CEO Director | Actinium Pharmaceuticals, I... (ATNM) | 02-Aug-17 | Purchase | 33,333 | $0.75 | $24,999.80 | 78% 42.5K to 75.83K | |
| 15-Jun-17 4:56 PM View: | Berger Mark Stanley Chief Medical Officer | Actinium Pharmaceuticals, I... (ATNM) | 15-Jun-17 | Purchase | 5,000 | $1.11 | $5,550.00 | 100% 0 to 5.0K | |
| 15-Jun-17 4:51 PM View: | O'Loughlin Steve Principal Financial Officer | Actinium Pharmaceuticals, I... (ATNM) | 15-Jun-17 | Purchase | 3,500 | $1.17 | $4,095.00 | 100% 0 to 3.5K | |
| 15-Jun-17 4:54 PM View: | Seth Sandesh Chairman and CEO Director | Actinium Pharmaceuticals, I... (ATNM) | 15-Jun-17 | Purchase | 7,500 | $1.16 | $8,725.00 | 21% 35.0K to 42.5K | |
| 03-Jan-17 8:00 AM View: | Seth Sandesh Executive Chairman Director | Actinium Pharmaceuticals, I... (ATNM) | 30-Dec-16 | Purchase | 5,000 | $0.88 | $4,400.00 | 17% 30.0K to 35.0K | |
| 12-Dec-16 4:44 PM View: | Seth Sandesh Executive Chairman Director | Actinium Pharmaceuticals, I... (ATNM) | 12-Dec-16 | Purchase | 5,000 | $0.98 | $4,900.00 | 20% 25.0K to 30.0K | |
| 01-Sep-16 5:01 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 31-Aug-16 | Sale | 136,853 | $1.83 | $251,118.00 | (3%) 4.85M to 4.71M | |
| 01-Sep-16 5:01 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 30-Aug-16 | Sale | 56,074 | $1.81 | $101,254.00 | (1%) 4.9M to 4.85M | |
| 30-Aug-16 5:07 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 29-Aug-16 | Sale | 25,000 | $1.72 | $42,875.00 | (< 1%) 4.93M to 4.9M | |
| 30-Aug-16 5:07 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 26-Aug-16 | Sale | 25,000 | $1.70 | $42,620.00 | (< 1%) 4.95M to 4.93M | |
| 17-Aug-16 4:05 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 16-Aug-16 | Sale | 5,029 | $1.72 | $8,651.88 | (< 1%) 4.96M to 4.95M | |
| 17-Aug-16 4:05 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 15-Aug-16 | Sale | 4,439 | $1.72 | $7,635.08 | (< 1%) 4.96M to 4.96M | |
| 14-Jul-16 4:29 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 12-Jul-16 | Sale | 3,100 | $1.80 | $5,581.00 | (< 1%) 4.97M to 4.96M | |
| 12-Jul-16 5:11 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 11-Jul-16 | Sale | 800 | $1.80 | $1,440.00 | (< 1%) 4.97M to 4.97M | |
| 12-Jul-16 5:11 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 08-Jul-16 | Sale | 21,190 | $1.80 | $38,142.00 | (< 1%) 4.99M to 4.97M | |
| 07-Jul-16 4:24 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 06-Jul-16 | Sale | 10,500 | $1.80 | $18,900.00 | (< 1%) 5.0M to 4.99M | |
| 07-Jul-16 4:24 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 05-Jul-16 | Sale | 10,340 | $1.82 | $18,862.20 | (< 1%) 5.01M to 5.0M | |
| 05-Jul-16 4:36 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 01-Jul-16 | Sale | 128,950 | $1.81 | $233,897.00 | (3%) 5.14M to 5.01M | |
| 05-Jul-16 4:36 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 30-Jun-16 | Sale | 19,150 | $1.80 | $34,539.20 | (< 1%) 5.16M to 5.14M | |
| 17-Jun-16 4:35 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 15-Jun-16 | Sale | 33,619 | $1.90 | $63,876.10 | (< 1%) 5.19M to 5.16M | |
| 06-Jun-16 7:20 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 02-Jun-16 | Sale | 17,790 | $2.01 | $35,715.80 | (< 1%) 5.21M to 5.19M | |
| 02-Jun-16 4:21 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 01-Jun-16 | Sale | 40,114 | $2.09 | $83,837.70 | (< 1%) 5.25M to 5.21M | |
| 02-Jun-16 4:21 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 31-May-16 | Sale | 129,336 | $1.93 | $249,547.00 | (2%) 5.38M to 5.25M | |
| 31-May-16 6:58 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 26-May-16 | Sale | 40,068 | $1.92 | $77,060.60 | (< 1%) 5.42M to 5.38M | |
| 26-May-16 5:43 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 25-May-16 | Sale | 36,400 | $1.90 | $69,235.50 | (< 1%) 5.45M to 5.42M | |
| 26-Apr-16 5:25 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 26-Apr-16 | Sale | 6,500 | $1.96 | $12,725.00 | (< 1%) 5.46M to 5.45M | |
| 26-Apr-16 5:25 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 25-Apr-16 | Sale | 18,385 | $2.02 | $37,204.00 | (< 1%) 5.48M to 5.46M | |
| 26-Apr-16 5:25 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 22-Apr-16 | Sale | 27,692 | $2.07 | $57,336.20 | (< 1%) 5.51M to 5.48M | |
| 21-Apr-16 4:56 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 21-Apr-16 | Sale | 13,000 | $2.04 | $26,557.00 | (< 1%) 5.52M to 5.51M | |
| 21-Apr-16 4:56 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 20-Apr-16 | Sale | 33,497 | $2.03 | $68,041.60 | (< 1%) 5.55M to 5.52M | |
| 21-Apr-16 4:56 PM View: | Memorial Sloan-Kettering Ca... 10% Owner | Actinium Pharmaceuticals, I... (ATNM) | 19-Apr-16 | Sale | 150,000 | $2.03 | $304,321.00 | (3%) 5.7M to 5.55M | |
| 18-Apr-16 5:26 PM View: | Seth Sandesh Director | Actinium Pharmaceuticals, I... (ATNM) | 18-Apr-16 | Purchase | 6,500 | $1.98 | $12,885.00 | 35% 18.5K to 25.0K | |
| 18-Apr-16 5:26 PM View: | Seth Sandesh Director | Actinium Pharmaceuticals, I... (ATNM) | 15-Apr-16 | Purchase | 3,500 | $2.00 | $7,015.00 | 23% 15.0K to 18.5K | |
| 18-Apr-16 5:24 PM View: | Traversa Sergio Director | Actinium Pharmaceuticals, I... (ATNM) | 15-Apr-16 | Purchase | 1,000 | $2.02 | $2,020.00 | 50% 2.0K to 3.0K |
